221 related articles for article (PubMed ID: 23252363)
1. Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30.
Chiu L; Chiu N; Zeng L; Zhang L; Popovic M; Chow R; Lam H; Poon M; Chow E
Expert Rev Pharmacoecon Outcomes Res; 2012 Dec; 12(6):831-7. PubMed ID: 23252363
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
Caissie A; Nguyen J; Chen E; Zhang L; Sahgal A; Clemons M; Kerba M; Arnalot PF; Danjoux C; Tsao M; Barnes E; Holden L; Danielson B; Chow E
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1238-45. PubMed ID: 22172909
[TBL] [Abstract][Full Text] [Related]
3. The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review.
Leung A; Lien K; Zeng L; Nguyen J; Caissie A; Culleton S; Holden L; Chow E
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):693-700. PubMed ID: 22098285
[TBL] [Abstract][Full Text] [Related]
4. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
[TBL] [Abstract][Full Text] [Related]
5. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
Taphoorn MJ; Claassens L; Aaronson NK; Coens C; Mauer M; Osoba D; Stupp R; Mirimanoff RO; van den Bent MJ; Bottomley A;
Eur J Cancer; 2010 Apr; 46(6):1033-40. PubMed ID: 20181476
[TBL] [Abstract][Full Text] [Related]
6. Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients.
Zahid N; Martins RS; Zahid W; Khalid W; Azam I; Bhamani SS; Asad N; Ahmad K; Jabbar AA; Shamim MS; Khan RJ; Javed G; Bari E; Enam SA
J Patient Rep Outcomes; 2021 Sep; 5(1):79. PubMed ID: 34487251
[TBL] [Abstract][Full Text] [Related]
7. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of overall quality of life in advanced cancer patients using EORTC QLQ-C30.
Cramarossa G; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Lam H; Pulenzas N; Chow E
Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):139-46. PubMed ID: 24325545
[TBL] [Abstract][Full Text] [Related]
9. Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases.
Wong E; Zhang L; Kerba M; Arnalot PF; Danielson B; Tsao M; Bedard G; Thavarajah N; Cheon P; Danjoux C; Pulenzas N; Chow E
Support Care Cancer; 2015 Sep; 23(9):2731-7. PubMed ID: 25663577
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of health-related quality of life in Lithuanian brain tumor patients using the EORTC brain cancer module.
Bunevičius A; Tamašauskas Š; Tamašauskas A; Deltuva V
Medicina (Kaunas); 2012; 48(11):588-94. PubMed ID: 23455894
[TBL] [Abstract][Full Text] [Related]
11. Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22.
Zeng L; Chow E; Bedard G; Zhang L; Fairchild A; Vassiliou V; Alm El-Din MA; Jesus-Garcia R; Kumar A; Forges F; Tseng LM; Hou MF; Chie WC; Bottomley A
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e337-42. PubMed ID: 22763028
[TBL] [Abstract][Full Text] [Related]
12. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
14. Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice.
Erharter A; Giesinger J; Kemmler G; Schauer-Maurer G; Stockhammer G; Muigg A; Hutterer M; Rumpold G; Sperner-Unterweger B; Holzner B
J Pain Symptom Manage; 2010 Feb; 39(2):219-29. PubMed ID: 20152586
[TBL] [Abstract][Full Text] [Related]
15. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
[TBL] [Abstract][Full Text] [Related]
16. Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires.
Cheung YB; Goh C; Thumboo J; Khoo KS; Wee J
J Clin Oncol; 2005 Aug; 23(22):4936-44. PubMed ID: 16051946
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the EORTC QLQ-BM22 and the BOMET-QOL quality of life questionnaires in patients with bone metastases.
Bedard G; Zeng L; Poon M; Lam H; Lauzon N; Chow E
Asia Pac J Clin Oncol; 2014 Jun; 10(2):118-23. PubMed ID: 23551978
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data.
Bordeleau L; Szalai JP; Ennis M; Leszcz M; Speca M; Sela R; Doll R; Chochinov HM; Navarro M; Arnold A; Pritchard KI; Bezjak A; Llewellyn-Thomas HA; Sawka CA; Goodwin PJ
J Clin Oncol; 2003 May; 21(10):1944-51. PubMed ID: 12743147
[TBL] [Abstract][Full Text] [Related]
20. Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer.
Bedard G; Zeng L; Zhang L; Lauzon N; Holden L; Tsao M; Danjoux C; Barnes E; Sahgal A; Poon M; Chow E
Asia Pac J Clin Oncol; 2014 Jun; 10(2):109-17. PubMed ID: 23551530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
